Literature Citations
1. In Vitro Inhibition of Mycobacterium tuberculosis beta-Carbonic anhydrase 3 with Mono- and Dithiocarbamates and Evaluation of their Toxicity Using Zebrafish Developing Embryos. Aspatwar, A., M. Hammaren, M. Parikka, S. Parkkila, F. Carta, M. Bozdag, D. Vullo, and C.T. Supuran. Journal of Enzyme Inhibition and Medicinal Chemistry, 2020. 35(1): p. 65-71. PMID[31663386]. PMCID[PMC6830242].
[PubMed]. TB_11_2019.
2. Design and Synthesis of Some New 3-Oxo/Thioxo-1,2,4-triazolo[4,3-a]benzimidazole Derivatives Bearing a 4-Tollyl sulfonyl Moiety as Antimycobacterial Agents. Bakhotmah, D.A. and A.A. Al-Ahmadi. Polycyclic Aromatic Compounds, 2019. ISI[000494063300001].
[WOS]. TB_11_2019.
3. Polymeric Nanobiotics as a Novel Treatment for Mycobacterial Infections. Batalha, I.L., A. Bernut, M. Schiebler, M.M. Ouberai, C. Passemar, C. Klapholz, S. Kinna, S. Michel, K. Sader, P. Castro-Hartmann, S.A. Renshaw, M.E. Welland, and R.A. Floto. Journal of Controlled Release, 2019. 314: p. 116-124. PMID[31647980].
[PubMed]. TB_11_2019.
4. New Insight into Structure-activity of Furan-based Salicylate Synthase (MbtI) Inhibitors as Potential Antitubercular Agents. Chiarelli, L.R., M. Mori, G. Beretta, A. Gelain, E. Pini, J.C. Sammartino, G. Stelitano, D. Barlocco, L. Costantino, M. Lapillo, G. Poli, I. Caligiuri, F. Rizzolio, M. Bellinzoni, T. Tuccinardi, S. Villa, and F. Meneghetti. Journal of Enzyme Inhibition and Medicinal Chemistry, 2019. 34(1): p. 823-828. PMID[30889995]. PMCID[PMC6427685].
[PubMed]. TB_11_2019.
5. Identification of Novel Scaffolds Targeting Mycobacterium tuberculosis. Dal Molin, M., P. Selchow, D. Schafle, A. Tschumi, T. Ryckmans, S. Laage-Witt, and P. Sander. Journal of Molecular Medicine, 2019. 97(11): p. 1601-1613. PMID[31728550].
[PubMed]. TB_11_2019.
6. A Piperidinol-containing Molecule Is Active against Mycobacterium tuberculosis by Inhibiting the Mycolic acid Flippase Activity of MmpL3. Dupont, C., Y. Chen, Z. Xu, F. Roquet-Baneres, M. Blaise, A.K. Witt, F. Dubar, C. Biot, Y. Guerardel, F.P. Maurer, S.S. Chng, and L. Kremer. Journal of Biological Chemistry, 2019. 294(46): p. 17512-17523. PMID[31562241]. PMCID[PMC6873192].
[PubMed]. TB_11_2019.
7. Benzofuran-Isatin Hybrids and their in Vitro Anti-mycobacterial Activities against Multi-drug Resistant Mycobacterium tuberculosis. Gao, F., L. Ye, Y. Wang, F. Kong, S. Zhao, J. Xiao, and G. Huang. European Journal of Medicinal Chemistry, 2019. 183: 111678. PMID[31525660].
[PubMed]. TB_11_2019.
8. Bimodal Actions of a Naphthyridone/Aminopiperidine-based Antibacterial That Targets Gyrase and Topoisomerase IV. Gibson, E.G., A.A. Oviatt, M. Cacho, K.C. Neuman, P.F. Chan, and N. Osheroff. Biochemistry, 2019. 58(44): p. 4447-4455. PMID[31617352].
[PubMed]. TB_11_2019.
9. Dimeric Benzoboroxoles for Targeted Activity against Mycobacterium tuberculosis. Guy, C.S., K. Murray, M.I. Gibson, and E. Fullam. Organic and Biomolecular Chemistry, 2019. 17(43): p. 9524-9528. PMID[31659363].
[PubMed]. TB_11_2019.
10. Design, Synthesis and Evaluation of Biological Activities of Some Novel anti-TB Agents with Bio-reducible Functional Group. Khani-Meinagh, H., H. Mostafavi, N. Reiling, M. Mahdavi, and G. Zarrini. BioImpacts, 2019. 9(4): p. 199-209. ISI[000494014400002].
[WOS]. TB_11_2019.
11. Role of Ethambutol and Rifampicin in the Treatment of Mycobacterium avium Complex Pulmonary Disease. Kim, H.J., J.S. Lee, N. Kwak, J. Cho, C.H. Lee, S.K. Han, and J.J. Yim. BMC Pulmonary Medicine, 2019. 19(1): p. 212-221. PMID[31711459]. PMCID[PMC6849249].
[PubMed]. TB_11_2019.
12. Design, Docking, Synthesis and Biological Evaluation of Novel Isoindole-1,3-(2H)-diones. Kumar, T.R. and L.V.V. Krishna. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2019. 58(9): p. 1056-1062. ISI[000495145900007].
[WOS]. TB_11_2019.
13. Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus. Malin, J.J., S. Winter, E. van Gumpel, G. Plum, and J. Rybniker. Antimicrobial Agents and Chemotherapy, 2019. 63(11): e1008-1019. PMID[31427298]. PMCID[PMC6811439].
[PubMed]. TB_11_2019.
14. Synthesis of 1,3,4-Oxadiazole and Imidazo[1,2-a]pyridine Based Molecular Hybrids and Their in Vitro Antituberculosis and Cytotoxicity Studies. Maurya, S.S., T.P. Gosain, S. Kidwai, R. Sing, and D.S. Rawat. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2019. 58(9): p. 1005-1018. ISI[000495145900001].
[WOS]. TB_11_2019.
15. Phenolic Compounds of Iris adriatica and their Antimycobacterial Effects. Ochensberger, S., F. Alperth, B. Mitic, O. Kunert, S. Mayer, M.F. Mourao, I. Turek, S.V. Luca, K. Skalicka-Wozniak, Z. Males, D. Hrusevar, I. Duka, and F. Bucar. Acta Pharmaceutica, 2019. 69(4): p. 673-681. PMID[31639092].
[PubMed]. TB_11_2019.
16. Some New Hydrazone Derivatives Bearing the 1,2,4-Triazole Moiety as Potential Antimycobacterial Agents. Ozadali Sari, K., O. Unsal Tan, D. Sriram, and A. Balkan. Turkish Journal of Pharmaceutical Sciences, 2019. 16(4): p. 432-436. ISI[000496508100008].
[WOS]. TB_11_2019.
17. 3,4-Dihydropyrimidin-2(1H)-one Analogues: Microwave Irradiated Synthesis with Antimicrobial and Antituberculosis Study. Patel, N., S. Pathan, and H.I. Soni. Current Microwave Chemistry, 2019. 6(1): p. 61-70. ISI[000493133200008].
[WOS]. TB_11_2019.
18. Activity of N-Phenylpiperazine Derivatives against Bacterial and Fungal Pathogens. Pospisilova, S., P. Marvanova, J. Treml, A.M. Moricz, P.G. Ott, P. Mokry, K. Odehnalova, O. Sedo, A. Cizek, and J. Jampilek. Current Protein and Peptide Science, 2019. 20(11): p. 1119-1129. PMID[31518219].
[PubMed]. TB_11_2019.
19. Itaconyl-CoA Forms a Stable Biradical in Methylmalonyl-CoA Mutase and Derails Its Activity and Repair. Ruetz, M., G.C. Campanello, M. Purchal, H. Shen, L. McDevitt, H. Gouda, S. Wakabayashi, J. Zhu, E.J. Rubin, K. Warncke, V.K. Mootha, M. Koutmos, and R. Banerjee. Science, 2019. 366(6465): p. 589-593. PMID[31672889].
[PubMed]. TB_11_2019.
20. In Vitro and in Vivo Toxicity Evaluation of Non-neuroleptic Phenothiazines, Antitubercular Drug Candidates. Salie, S., A. Labuschagne, A. Walters, S. Geyer, A. Jardine, M. Jacobs, and N.J. Hsu. Regulatory Toxicology and Pharmacology, 2019. 109: 104508. PMID[31672509].
[PubMed]. TB_11_2019.
21. A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link between Mycobacterial Infection and Autoimmune Diseases. Sudomova, M., M.A. Shariati, J. Echeverria, I. Berindan-Neagoe, S.M. Nabavi, and S.T.S. Hassan. Marine Drugs, 2019. 17(11): p. 641-653. PMID[31739453].
[PubMed]. TB_11_2019.
22. Transferrin Conjugates of Antitubercular Drug Isoniazid: Synthesis and in Vitro Efficacy. Sutar, Y.B., J.K. Mali, V.N. Telvekar, R.S. Rajmani, and A. Singh. European Journal of Medicinal Chemistry, 2019. 183: 111713. PMID[31557610].
[PubMed]. TB_11_2019.
23. Design and Synthesis of Sulfur Cross-linked 1,3,4-Oxadiazole-nitro(furan/thiophene)-propenones as Dual Inhibitors of Inflammation and Tuberculosis: Molecular Docking and Hirshfeld Surface Analysis. Turukarabettu, V., B. Kalluraya, and M. Sharma. Monatshefte fur Chemie, 2019. 150(11): p. 1999-2010. ISI[000493493100001].
[WOS]. TB_11_2019.
Patent Citations
This month, no relevant Mycobacterium patents were identified.